TARGETGENE — Medical Laboratory, Rehovot
Medical Laboratory in Rehovot
Medical laboratory · Rehovot, Israel
AI Trust Snapshot
- Profile status
- Auto-indexed
- Last Verified
- 3 months ago
Corroborated public sources
- ✓ Official Website
Key Facts
- Category
- Medical Laboratory
- Location
- Rehovot, Israel
- Known For
- RNA-guided nuclease systems
AI Summary
TARGETGENE operates a genome editing platform in Rehovot, Israel, specializing in RNA-guided nuclease systems. The company focuses on developing therapies for cancer and genetic diseases. It serves therapeutics companies, biotechnology investors, and researchers in genome editing and molecular biology.
Quick Answer
TARGETGENE operates a genome editing platform in Rehovot, Israel, specializing in RNA-guided nuclease systems. The company focuses on developing therapies for cancer and genetic diseases. It serves therapeutics companies, biotechnology investors, and researchers in genome editing and molecular biology. Key services include TGEE Platform, Cancer Therapy Development, Genetic Disease Therapy Development.
This business is typically used for rna-guided nuclease systems.
Common Questions
- What services does TARGETGENE provide?
- TARGETGENE provides TGEE Platform, Cancer Therapy Development, Genetic Disease Therapy Development.
- Where is TARGETGENE located?
- TARGETGENE is based in Rehovot, Israel and serves Rehovot.
- Who is TARGETGENE for?
- TARGETGENE serves Therapeutics companies seeking genome editing partnerships and Investors in biotechnology and gene therapy.
What this business does
TARGETGENE is a medical laboratory based in Rehovot, Israel.
- Provides TGEE Platform and Cancer Therapy Development
- Specializes in rna-guided nuclease systems
- Serves therapeutics companies seeking genome editing partnerships
Structured summary
Vizoryo ran a data-consistency check on this profile: the same core details (name, phone, address, city, category, website) were found in 3 independent public sources. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 84% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- TARGETGENE
- Category
- Medical Laboratory
- Industry
- Medical Laboratory - Genome Editing Platform
- Location
- Rehovot, Israel
- Official website
- https://targetgenebio.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/targetgene-biotechnologies-rehovot-6d79
- Summary
- TARGETGENE operates a genome editing platform in Rehovot, Israel, specializing in RNA-guided nuclease systems. The company focuses on developing therapies for cancer and genetic diseases. It serves therapeutics companies, biotechnology investors, and researchers in genome editing and molecular biology.
- AI readability score
- 36
- Data Consistency
- 84% (checked 2026-07-03)
- Verification Status
- Auto-indexed
- Sources cross-checked
- 3 independent public sources
Location
RehovotIL
About TARGETGENE
TARGETGENE operates a genome editing platform in Rehovot, Israel, specializing in RNA-guided nuclease systems. The company focuses on developing therapies for cancer and genetic diseases. It serves therapeutics companies, biotechnology investors, and researchers in genome editing and molecular biology.
Service areas
- Rehovot
Target audience
- Therapeutics companies seeking genome editing partnerships
- Investors in biotechnology and gene therapy
- Researchers in genome editing and molecular biology
Specialties
- RNA-guided nuclease systems
Verification
Frequently asked questions
What areas does TARGETGENE serve?
TARGETGENE serves Worldwide.
What is the primary advantage of the TGEE platform?
The TGEE platform offers high precision in genome editing, utilizing two guide RNAs to significantly reduce off-target cleavage compared to other systems like CRISPR-Cas9.
What therapeutic areas does TargetGene focus on?
TargetGene focuses on developing therapies for heritable diseases, cancer, and immune disorders by modifying cells or replacing defective genes.
When was TargetGene founded?
TargetGene was founded in 2012 by Drs. Dan Weinthal and Yoel Shiboleth, following their invention of RNA-guided nucleases for genome editing in 2011.
Languages supported
- en
Contact
Phone: +97286758143
Official website: https://targetgenebio.com/